Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xin Cao
Observed name:
X Cao
Institution:
Tianjin Medical University General Hospital
Observed institution:
Tianjin Medical University General Hospital
ORCID:
0009-0008-7634-835X
Observed ORCID:
0009-0008-7634-835X
OpenAlex ID:
A5108148117
Integrative profiling of untreated primary membranous nephropathy at the single-cell transcriptome level
2024
·
Qiuhua Gu
, Yuchen Wen
, et al.
·
Clinical Kidney Journal
·
9
Long-term real-world outcomes of rituximab in primary membranous nephropathy: a 154-patient cohort study from China
2026
·
Yan Qi
, Xin Cao
, et al.
·
Renal Failure
·
3
OP02 Efficacy and safety of vedolizumab combined with upadacitinib as an 8-week induction strategy in moderate-to-severe ulcerative colitis: a multicenter, randomized controlled trial
2026
·
H Wu
, L Wu
, et al.
·
Journal of Crohn s and Colitis
·
1
PDF
Significance of glomerular IgG3 deposition in patients with primary membranous nephropathy
2026
·
Ming-Xuan Gao
, Zhen-Jun Zhao
, et al.
·
Autoimmunity
Show more works
View as search
Works count:
4
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type